Biotech vs. Shorts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (221)	9/16/1999 10:58:00 PM
From: Biomaven	Read Replies (1) of 427

Yeah, I guess I was being a little cutesy, trying to play off the title of the thread. LIPO is very much a biotech, however - a profitable one, even. I owned it for a while, as I thought it was a munch candidate, but then fortunately bailed at a good price a little while back when I thought it got too pricey. I know that you've never cared much for it, and Miljenko was certainly always plenty skeptical of Evacet. LIPO will certainly cause the shorts to look around for another biotech target. We may see a wider set of shorts next time - which will mean generally lower-quality and meaner attacks. I just hope we don't get some Asensio-type attacks on respectable biotechs. VPHM of course has done very nicely. There the shorts were the ignorant day-trader types, short-selling on the pop. I'm not convinced yet that GLIA's weakness is in fact short-engendered. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next